OLVIG
NEO icon

Oliver Lagore Vanvalin Investment Group’s NeoGenomics NEO Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-400
Closed -$5.9K – 716
2024
Q3 		$5.9K Hold
400
– – ﹤0.01% 485
2024
Q2 		$5.55K Hold
400
– – ﹤0.01% 487
2024
Q1 		$6.29K Hold
400
– – ﹤0.01% 477
2023
Q4 		$6.47K Hold
400
– – ﹤0.01% 486
2023
Q3 		$4.92K Hold
400
– – ﹤0.01% 555
2023
Q2 		$6.43K Hold
400
– – ﹤0.01% 540
2023
Q1 		$6.96K Hold
400
– – ﹤0.01% 440
2022
Q4 		$3.7K Hold
400
– – ﹤0.01% 504
2022
Q3 		$3K Sell
400
-750
-65% -$7.45K ﹤0.01% 500
2022
Q2 		$9K Buy
1,150
+750
+188% +$7.16K 0.01% 349
2022
Q1 		$5K Buy
+400
New +$8.42K ﹤0.01% 412

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's NEO Position: Q4 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 400 shares — an estimated $5.9K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in NEO in Q1 2022 and held it in 11 quarters. The position peaked at $9K in Q2 2022. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 400 NeoGenomics shares in Q4 2024, an estimated $5.9K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in NeoGenomics in Q1 2022 and held it in 11 quarters.
  • Oliver Lagore Vanvalin Investment Group's NeoGenomics position peaked at $9K in Q2 2022.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q4 2024, filed 1 Apr 2025.